共 46 条
[36]
CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells
[J].
ADVANCES IN MEDICAL SCIENCES,
2023, 68 (02)
:409-416